- “Sitagliptin Tablets” already exists in your wishlist
In Stock
Gliclazide Extended-Release Tablets
Gliclazide Extended-Release 60mg | Anti-Diabetic | Tablets
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic name: Gliclazide 60 mg extended-release (ER) tablets. Gliclazide is an oral blood-glucose-lowering medicine in the sulfonylurea class. The 60 mg strength is commonly supplied as a extended-release tablet; check the exact product pack and leaflet to confirm the formulation. This document is for general education and does not replace the approved package leaflet or advice from a qualified healthcare professional.
Product Introduction
Gliclazide 60 mg extended-release tablets are prescribed to help control blood glucose in adults with type 2 diabetes when diet, exercise and other lifestyle measures alone are not sufficient. Gliclazide stimulates the pancreas to release insulin. Extended-release tablets release the medicine gradually over time. Treatment is used together with a suitable meal plan, physical activity and blood-glucose monitoring. It is a prescription medicine and is not appropriate for everyone.
1. Uses
Used to improve blood-glucose control in adults with type 2 diabetes mellitus when lifestyle measures alone are inadequate.
May be prescribed alone or with other diabetes medicines when a clinician considers this appropriate.
It is not used to treat type 1 diabetes or diabetic ketoacidosis. Do not use it for any condition unless prescribed by a qualified clinician.
2. Benefits
Helps lower high blood glucose by stimulating insulin release from the pancreas.
When used with an appropriate diet, physical activity and monitoring, improved glucose control may help reduce the risk of long-term diabetes complications.
The extended-release formulation is designed to release gliclazide gradually, and is commonly taken once daily according to the product leaflet and prescription.
Benefits vary by person. Gliclazide can cause hypoglycaemia (low blood sugar), so treatment needs to be balanced with meal regularity, monitoring and individual risk factors.
3. Side Effects
Possible side effects include:
Low blood sugar (hypoglycaemia): sweating, shaking, strong hunger, headache, dizziness, palpitations, confusion, blurred vision or unusual behaviour. Severe cases can cause seizures or loss of consciousness.
Nausea, indigestion, abdominal discomfort, vomiting, diarrhoea or constipation.
Skin rash, itching or other allergic reactions.
Rarely, changes in liver function or blood-cell counts may occur.
If low blood sugar is suspected and the person is awake and able to swallow safely, follow their clinician-provided hypoglycaemia plan; fast-acting glucose is commonly used. If the person is unconscious, having a seizure or unable to swallow, do not give food or drink by mouth—seek emergency medical help immediately.
Seek urgent medical attention for severe or repeated hypoglycaemia, breathing difficulty or swelling of the face/throat, yellowing of the skin or eyes, dark urine, unusual bruising/bleeding, or a severe skin reaction.
4. Safety Advice
Take gliclazide only as prescribed. Do not start, stop or change the dose without consulting the prescriber.
Take it with breakfast or the meal specified by your product leaflet and clinician. Do not skip or delay meals; missed meals can trigger hypoglycaemia.
Check blood glucose as advised and attend scheduled reviews. Tell your healthcare professional about repeated low readings or symptoms.
People with kidney or liver problems, older adults, or people with irregular food intake may have a higher risk of low blood sugar and need careful assessment.
Tell your clinician about severe illness, adrenal/pituitary/thyroid disorders, G6PD deficiency, or any allergy to gliclazide or other sulfonylureas.
Avoid excessive alcohol and discuss alcohol use with your clinician because it can make glucose control less predictable.
Fever, infection, surgery, changes in diet or unusually strenuous activity can affect glucose levels. Ask your clinician for a sick-day plan.
Tell your healthcare professional if you are pregnant, planning pregnancy or breastfeeding; treatment may need to be changed. Do not change it yourself.
Low blood sugar may impair concentration and reaction time. Do not drive or operate machinery if you have symptoms or your glucose is low.
Keep out of reach of children and store according to the pack instructions.
5. How It Works
Gliclazide belongs to the sulfonylurea class. It stimulates pancreatic beta cells to release insulin, helping lower blood glucose. Because it increases insulin release, blood sugar may fall too low, particularly if meals are missed, food intake is reduced, exercise is unusually strenuous, or other glucose-lowering medicines are used.
6. How to Use
Follow the prescription label and the leaflet supplied with your exact product.
Gliclazide 60 mg extended-release tablets are commonly taken once daily with breakfast, but follow your prescriber’s exact directions.
Swallow with water. Some 60 mg extended-release tablets may be divided along the score line if the product leaflet permits; do not crush or chew them. Check the specific leaflet before splitting a tablet.
Do not skip meals after taking the medicine. Maintain regular meals according to your diabetes plan.
If you miss a dose, follow the leaflet or ask a pharmacist/doctor. Do not take a double dose to make up for a missed dose.
If you take more than prescribed or suspect an overdose, seek urgent medical advice because low blood sugar can be severe or prolonged.
Do not stop treatment because you feel well; discuss any change with your clinician.
7. Quick Tips
Take the tablet at the same time each day with the meal specified by your prescriber.
Learn the warning signs of low blood sugar and follow your clinician’s plan for treating it.
Keep a fast-acting source of glucose available if advised by your healthcare team.
Monitor blood glucose and HbA1c at the intervals recommended by your healthcare team.
Tell your doctor or pharmacist about all prescription medicines, over-the-counter medicines, vitamins, supplements and herbal products you use.
Keep meal times reasonably consistent and discuss major changes in diet or exercise with your healthcare team.
Do not share your medicine. Seek emergency help for unconsciousness, seizures or inability to swallow during suspected hypoglycaemia.
8. Drug Interactions
Several medicines can increase or reduce gliclazide’s effect on blood glucose. Tell your doctor and pharmacist about all medicines and supplements you use. This list is not exhaustive.
Other diabetes medicines, including insulin: may increase the risk of hypoglycaemia.
Some antifungal medicines (such as miconazole or fluconazole), certain antibiotics and other medicines may increase the glucose-lowering effect.
Corticosteroids (such as prednisolone), some diuretics, thyroid medicines and certain hormonal medicines may increase blood glucose or reduce gliclazide’s effect.
Some anti-inflammatory pain medicines (NSAIDs), salicylates and other medicines may increase the risk of low blood sugar in certain circumstances.
Beta-blockers may mask some warning signs of hypoglycaemia, such as a fast heartbeat.
Alcohol can make blood-glucose changes less predictable and may worsen adverse effects.
Do not start, stop or change any medicine without professional advice. Your clinician may need to monitor glucose more closely or adjust treatment.
| Product Name | Gliclazide Extended-Release Tablets |
| Category | All Medicines, Anti Diabetic |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 60mg |
|---|---|
| Type | Single API |
| Form | Tablets |
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
